Article
CST09RateCar-FINAL.pdf
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Daily Derm Times: May 22, 2025
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
FDA Approves Arcutis’ Roflumilast Foam for Plaque Psoriasis
Derm Dispatch: A Comprehensive Guide to Managing Eczema with Integrative Medicine
Real-World Data on the Adverse Effects of Apremilast and Deucravacitinib for Psoriasis
Ascletis Receives FDA Clearance to Advance ASC50, a Novel Oral IL-17 Inhibitor, Into Phase 1 Psoriasis Trial
Suicide Risk Management Crucial in Dermatological Care
Quoin Receives FDA Clearance for Second Netherton Trial